Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Exemplar
98.8
%
| 12 | 44.7 % | 6 | 98.8 % | -48.81% |
Biopharmaceuticals
1.2
%
| 15 | 55.3 % | 0 | 1.2 % | -99.50% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 99.1 % | 6 | 100.0 % | -76.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 01/20/01 |
Harry Thomasian
DFI | Director of Finance/CFO | 62 | 01/21/01 |
Randal Kirk
CHM | Chairman | 70 | 01/08/01 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rutul Shah
COO | Chief Operating Officer | - | - |
Investor Relations Contact | - | 01/18/01 | |
Jim Shaffer
PRN | Corporate Officer/Principal | - | - |
Rob Russell
HRO | Human Resources Officer | - | - |
Don Lehr
LAW | General Counsel | 49 | 01/09/01 |
Corporate Officer/Principal | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randal Kirk
CHM | Chairman | 70 | 01/08/01 |
Dean Mitchell
BRD | Director/Board Member | 68 | 01/09/01 |
Jeffrey Perez
PRN | Corporate Officer/Principal | 52 | 01/14/01 |
Fred Hassan
BRD | Director/Board Member | 78 | 30/16/30 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 28/11/28 |
Cesar Alvarez
BRD | Director/Board Member | 76 | 01/08/01 |
James Turley
BRD | Director/Board Member | 68 | 16/14/16 |
Steven Frank
BRD | Director/Board Member | 64 | 01/08/01 |
Director/Board Member | 56 | 25/17/25 | |
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 259,899,121 | 219,740,867 ( 84.55 %) | 7,479,431 ( 2.878 %) | 84.55 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+33.28% | 704B | |
+28.59% | 577B | |
-3.93% | 348B | |
+18.30% | 327B | |
+5.03% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.25% | 147B |